Aktie A0BK8V RESONANCE HEALTH LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Resonance Health Limited

Aktien

A0BK8V

AU000000RHT2

RHT

Markt geschlossen - Australian S.E.
Andere Börsenplätze
 07:47:45 19.04.2024 		% 5 Tage % 1. Jan.
0,081 AUD -4,71 % Intraday Chart für Resonance Health Limited +8,00 % +35,00 %
02.04. Resonance Health erwirbt Unternehmen für klinische Forschung MT
28.03. Resonance Health stoppt den Handel vor der Ankündigung einer "wesentlichen Akquisition MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Resonance Health to Acquire Clinical Research Company
Resonance Health Limited entered into Share Sale Agreement to acquire TrialsWest Pty Ltd from Helen Pavitt, Michelle Davies, and Peter Bremner for AUD 8 million.
Resonance Health Halts Trading Ahead of 'Material Acquisition' Announcement
Resonance Health Signs Collaboration Deal for Expansion Into Japanese Market
Resonance Health Changes Shareholder Registry Services Provider
Resonance Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Resonance Health Discloses 4.3% Reduction of Issued Shares
Resonance Health Appoints CFO
Resonance Health Ltd Appoints Benjamin Carruthers as Chief Financial Officer, Effective October 2023
Resonance Health Limited Announces Resignation of Liesl Ellies as Joint Company Secretary
Resonance Health Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Resonance Health Secures Services Deal for Australian Clinical Trial
Resonance Health Limited Announces Resignation of Nick Allan as Chief Financial Officer
Resonance Health Limited Announces Resignation of Nick Allan as COO and Joint Company Secretary
Resonance Health Gets FDA Clearance to Market HepaFatSmart in US
Resonance Health Appoints CEO
Resonance Health Limited Announces CEO Changes
Resonance Health Ltd Appoints Aaron Brinkworth as Non-Executive Director
Resonance Health Limited Reports Earnings Results for the Half Year Ended December 30, 2022
Resonance Health Files Patent for Liver Fibrosis Detection
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0BK8V Aktie
  4. Nachrichten Resonance Health Limited
  5. Andere Sprachen